Xuebin Liao

3.7k total citations
76 papers, 2.9k citations indexed

About

Xuebin Liao is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Xuebin Liao has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 17 papers in Pharmacology and 16 papers in Molecular Biology. Recurrent topics in Xuebin Liao's work include Catalytic C–H Functionalization Methods (18 papers), Alkaloids: synthesis and pharmacology (17 papers) and Catalytic Cross-Coupling Reactions (13 papers). Xuebin Liao is often cited by papers focused on Catalytic C–H Functionalization Methods (18 papers), Alkaloids: synthesis and pharmacology (17 papers) and Catalytic Cross-Coupling Reactions (13 papers). Xuebin Liao collaborates with scholars based in China, United States and United Kingdom. Xuebin Liao's co-authors include John F. Hartwig, James M. Cook, Jaclyn M. Murphy, Hao Zhou, Yahu A. Liu, Zhiqiang Weng, Carl W. Liskey, Lu Hu, Wenzhi Ji and Hui Chen and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Xuebin Liao

71 papers receiving 2.8k citations

Peers

Xuebin Liao

OC

MB

IC

PHARM

PS

Joseph M. Ready United States

Antonia F. Stepan United States

Xiangbing Qi China

Wenhu Duan China

Makoto Wada Japan

Andrew P. Combs United States

Amy B. Dounay United States

Mark G. Bock United States

Juhani Huuskonen Finland

Takayuki Doi Japan

Joseph M. Ready United States

Xuebin Liao

2.7k ×1.4

OC

902 ×1.6

MB

674 ×2.0

IC

142 ×0.4

PHARM

143 ×0.8

PS

Citations per year, relative to Xuebin Liao Xuebin Liao (= 1×) peers Joseph M. Ready

Countries citing papers authored by Xuebin Liao

Since Specialization

Citations

This map shows the geographic impact of Xuebin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebin Liao more than expected).

Fields of papers citing papers by Xuebin Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebin Liao. The network helps show where Xuebin Liao may publish in the future.

Co-authorship network of co-authors of Xuebin Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebin Liao. A scholar is included among the top collaborators of Xuebin Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebin Liao. Xuebin Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Chao, Yuanhao Wang, Maocai Luo, et al.. (2025). Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade. Journal of Experimental & Clinical Cancer Research. 44(1). 311–311.

2.

Zhang, Yixuan, Yushuang Chai, Tingting Lu, et al.. (2025). Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors. European Journal of Medicinal Chemistry. 290. 117488–117488.

3.

Chen, Hui, et al.. (2024). Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress. Expert Opinion on Therapeutic Targets. 28(4). 237–250. 11 indexed citations

4.

Ye, Jie, Tengfei Liu, Yahui Liu, et al.. (2024). YF550-C1, an E3 ligase inhibitor of CBL-B, to demonstrate T cell and NK cell activation and anti-tumor activities in syngeneic and PDX tumor model.. Journal of Clinical Oncology. 42(16_suppl). e14570–e14570. 1 indexed citations

5.

Zhang, Panpan, Yanru Qin, Jifang Gong, et al.. (2024). A phase I/II study to evaluate the safety, pharmacokinetics, and efficacy of PRJ1-3024 in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2590–2590. 1 indexed citations

6.

Chen, Hui, et al.. (2024). Nickel-catalyzed decarboxylative difluoromethylation and alkylation of alkenes. Chinese Chemical Letters. 36(3). 109954–109954. 1 indexed citations

7.

Li, Shasha, Wei Shao, Yan Gao, et al.. (2021). Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds. Science Advances. 7(4). 62 indexed citations

8.

Zhao, Hansen, Zhenrong Huang, Bin Xiong, et al.. (2021). Uncover Single Nanoparticle Dynamics on Live Cell Membrane with Data-Driven Historical Experience Analysis. Analytical Chemistry. 93(27). 9559–9567. 1 indexed citations

9.

Gao, Yan, Lei He, Shuhao Sun, et al.. (2021). Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy. Journal of Medicinal Chemistry. 64(11). 7507–7532. 28 indexed citations

10.

Zhang, Xu, Bo Lei, Yuan Yuan, et al.. (2020). Brain control of humoral immune responses amenable to behavioural modulation. Nature. 581(7807). 204–208. 224 indexed citations

11.

Liu, Yahu A., Xuebin Liao, & Hui Chen. (2020). Recent Progress in Radical Decarboxylative Functionalizations Enabled by Transition-Metal (Ni, Cu, Fe, Co or Cr) Catalysis. Synthesis. 53(1). 1–29. 41 indexed citations

12.

Chen, Hui, Shuhao Sun, Yahu A. Liu, & Xuebin Liao. (2019). Nickel-Catalyzed Cyanation of Aryl Halides and Hydrocyanation of Alkynes via C–CN Bond Cleavage and Cyano Transfer. ACS Catalysis. 10(2). 1397–1405. 72 indexed citations

13.

Chen, Hui, Shuhao Sun, & Xuebin Liao. (2019). Nickel-Catalyzed Decarboxylative Alkenylation of Anhydrides with Vinyl Triflates or Halides. Organic Letters. 21(10). 3625–3630. 23 indexed citations

14.

Ji, Wenzhi, Chen‐Long Li, Hui Chen, Zhi‐Xiang Yu, & Xuebin Liao. (2019). A newly designed heterodiene and its application to construct six-membered heterocycles containing an N–O bond. Chemical Communications. 55(80). 12012–12015. 5 indexed citations

15.

Chen, Hui, et al.. (2018). Nickel-Catalyzed Decarboxylative Alkylation of Aryl Iodides with Anhydrides. ACS Catalysis. 8(11). 10479–10485. 21 indexed citations

16.

Hu, Lu, Yahu A. Liu, & Xuebin Liao. (2017). In situ generation of N-unsubstituted imines from alkyl azides and their applications for imine transfer via copper catalysis. Science Advances. 3(8). e1700826–e1700826. 14 indexed citations

17.

Xia, Tingting, Lei He, Yahu A. Liu, John F. Hartwig, & Xuebin Liao. (2017). Palladium-Catalyzed Cross-Coupling of Ethyl Bromodifluoroacetate with Aryl Bromides or Triflates and Cross-Coupling of Ethyl Bromofluoroacetate with Aryl Iodides. Organic Letters. 19(10). 2610–2613. 44 indexed citations

18.

Xia, Tingting, Zhenyi Hu, Wenzhi Ji, et al.. (2017). Synthesis of withasomnine and pyrazole derivatives via intramolecular dehydrogenative cyclization, as well as biological evaluation of withasomnine-based scaffolds. Organic Chemistry Frontiers. 5(5). 850–854. 12 indexed citations

19.

Ji, Wenzhi, Yahu A. Liu, & Xuebin Liao. (2016). Transition‐Metal‐Free Synthesis of N‐Hydroxy Oxindoles by an Aza‐Nazarov‐Type Reaction Involving Azaoxyallyl Cations. Angewandte Chemie International Edition. 55(42). 13286–13289. 38 indexed citations

20.

Ji, Wenzhi, Yahu A. Liu, & Xuebin Liao. (2016). Transition‐Metal‐Free Synthesis of N‐Hydroxy Oxindoles by an Aza‐Nazarov‐Type Reaction Involving Azaoxyallyl Cations. Angewandte Chemie. 128(42). 13480–13483. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact